NCT01005199 Sorafenib Tosylate With or Without Everolimus in Treating Patients With Localized, Unresectable, or Metastatic Liver Cancer Status COMPLETED Phase PHASE2
NCT00994370 Measurement of Pro-angiogenic Markers in Patients With Hepatic Metastases Undergoing SIRT Status COMPLETED Phase N/A
NCT00987766 Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer Status COMPLETED Phase PHASE1
NCT00980239 HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver Status COMPLETED Phase PHASE1
NCT00976898 Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma Status COMPLETED Phase NA
NCT00956930 Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery Status COMPLETED Phase PHASE2
NCT00950144 Studying Pain and Symptom Distress in Patients With Advanced Colon Cancer, Rectal Cancer, Pancreatic Cancer, or Liver Cancer Status COMPLETED Phase N/A
NCT00949182 Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery Status COMPLETED Phase PHASE2
NCT00941967 Sorafenib With or Without Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Liver Cancer Status COMPLETED Phase PHASE2
NCT00910572 Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT00906984 TheraSphere® for Treatment of Unresectable Hepatocellular Carcinoma Status APPROVED_FOR_MARKETING Phase N/A
NCT00903396 Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer Status TERMINATED Phase PHASE2
NCT00902343 Controlled Trial Comparing Nomogram-based Versus Standard Allocation of Acute Normovolemic Hemodilution (ANH) During Hepatic Resection Status COMPLETED Phase PHASE3
NCT00900094 UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer Status COMPLETED Phase N/A
NCT00899002 Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer Status WITHDRAWN Phase N/A
NCT00896467 Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy Status TERMINATED Phase N/A
NCT00881751 Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer Status COMPLETED Phase PHASE2